Development of a novel liquid biopsy test to assist targeted MSI-h cancer treatment
Ended Project Grant Awarded Last action
- Award ID
- R43CA232914
- Recipient
-
GLC Biotechnology Inc. UEI ETKMDA959PF6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Ohio, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $225,000 |
Quick answers
Who received award R43CA232914?
R43CA232914 was awarded to GLC Biotechnology Inc. by National Cancer Institute (National Institutes of Health) on August 14, 2018.
How much is award R43CA232914 worth?
$225,000 has been obligated on R43CA232914.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award